Skip to main content
Top
Published in:

18-06-2023 | Enterostomy | Review

Clinical management of high-output stoma: a systematic literature review and meta-analysis

Authors: H. Lederhuber, L. H. Massey, V. E. Kantola, M. R. S. Siddiqui, A. E. Sayers, F. D. McDermott, I. R. Daniels, N. J. Smart

Published in: Techniques in Coloproctology | Issue 12/2023

Login to get access

Abstract

Purpose

High output is a common complication after stoma formation. Although the management of high output is described in the literature, there is a lack of consensus on definitions and treatment. Our aim was to review and summarise the current best evidence.

Methods

MEDLINE, Cochrane Library, BNI, CINAHL, EMBASE, EMCARE, and ClinicalTrials.gov were searched from 1 Jan 2000 to 31 Dec 2021 for relevant articles on adult patients with a high-output stoma. Patients with enteroatmospheric fistulas and case series/reports were excluded. Risk of bias was assessed using RoB2 and MINORS. The review was registered in PROSPERO (CRD42021226621).

Results

The search strategy identified 1095 articles, of which 32 studies with 768 patients met the inclusion criteria. These studies comprised 15 randomised controlled trials, 13 non-randomised prospective trials, and 4 retrospective cohort studies. Eighteen different interventions were assessed. In the meta-analysis, there was no difference in stoma output between controls and somatostatin analogues (g − 1.72, 95% CI − 4.09 to 0.65, p = 0.11, I2 = 88%, t2 = 3.09), loperamide (g − 0.34, 95% CI − 0.69 to 0.01, p = 0.05, I2 = 0%, t2 = 0) and omeprazole (g − 0.31, 95% CI  − 2.46 to 1.84, p = 0.32, I2 = 0%, t2 = 0). Thirteen randomised trials showed high concern of bias, one some concern, and one low concern. The non-randomised/retrospective trials had a median MINORS score of 12 out of 24 (range 7–17).

Conclusion

There is limited high-quality evidence favouring any specific widely used drug over the others in the management of high-output stoma. Evidence, however, is weak due to inconsistent definitions, risk of bias and poor methodology in the existing studies. We recommend the development of validated core descriptor and outcomes sets, as well as patient-reported outcome measures.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harris DA, Egbeare D, Jones S, Benjamin H, Woodward A, Foster ME (2005) Complications and mortality following stoma formation. Ann R Coll Surg Engl 87(6):427–431PubMedPubMedCentralCrossRef Harris DA, Egbeare D, Jones S, Benjamin H, Woodward A, Foster ME (2005) Complications and mortality following stoma formation. Ann R Coll Surg Engl 87(6):427–431PubMedPubMedCentralCrossRef
2.
go back to reference Nightingale J (2001) Intestinal failure. London: Greenwich Medical Media Nightingale J (2001) Intestinal failure. London: Greenwich Medical Media
3.
go back to reference Phillips SF, Giller J (1973) The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med 81(5):733–746PubMed Phillips SF, Giller J (1973) The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med 81(5):733–746PubMed
4.
go back to reference Debongnie JC, Phillips SF (1978) Capacity of the human colon to absorb fluid. Gastroenterology 74(4):698–703PubMedCrossRef Debongnie JC, Phillips SF (1978) Capacity of the human colon to absorb fluid. Gastroenterology 74(4):698–703PubMedCrossRef
5.
go back to reference Nightingale J, Woodward JM, Small Bowel and Nutrition Committee of the British Society of Gastroenterology (2006) Guidelines for management of patients with a short bowel. Gut 55(Suppl 4):iv1–iv12PubMedPubMedCentral Nightingale J, Woodward JM, Small Bowel and Nutrition Committee of the British Society of Gastroenterology (2006) Guidelines for management of patients with a short bowel. Gut 55(Suppl 4):iv1–iv12PubMedPubMedCentral
6.
go back to reference Williams RN, Hemingway D, Miller AS (2009) Enteral Clostridium difficile, an emerging cause for high-output ileostomy. J Clin Pathol 62(10):951–953PubMedCrossRef Williams RN, Hemingway D, Miller AS (2009) Enteral Clostridium difficile, an emerging cause for high-output ileostomy. J Clin Pathol 62(10):951–953PubMedCrossRef
7.
go back to reference Hanna S, Mac II (1960) The influence of aldosterone on magnesium metabolism. Lancet 2(7146):348–350PubMedCrossRef Hanna S, Mac II (1960) The influence of aldosterone on magnesium metabolism. Lancet 2(7146):348–350PubMedCrossRef
8.
go back to reference Hessov I, Andersson H, Isaksson B (1983) Effects of a low-fat diet on mineral absorption in small-bowel disease. Scand J Gastroenterol 18(4):551–554PubMedCrossRef Hessov I, Andersson H, Isaksson B (1983) Effects of a low-fat diet on mineral absorption in small-bowel disease. Scand J Gastroenterol 18(4):551–554PubMedCrossRef
9.
10.
go back to reference Ovesen L, Chu R, Howard L (1983) The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 38(2):270–277PubMedCrossRef Ovesen L, Chu R, Howard L (1983) The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 38(2):270–277PubMedCrossRef
11.
go back to reference Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI (1992) Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 33(11):1493–1497PubMedPubMedCentralCrossRef Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI (1992) Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 33(11):1493–1497PubMedPubMedCentralCrossRef
12.
13.
go back to reference Higgins JPT, Thomas J, Chandler J et al (2022) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane Collaboration Higgins JPT, Thomas J, Chandler J et al (2022) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane Collaboration
14.
go back to reference Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906PubMedCrossRef Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906PubMedCrossRef
15.
go back to reference Page MJ, Moher D, Bossuyt PM, et al (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160PubMedPubMedCentralCrossRef Page MJ, Moher D, Bossuyt PM, et al (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160PubMedPubMedCentralCrossRef
17.
go back to reference Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898PubMedCrossRef Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898PubMedCrossRef
18.
go back to reference Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716PubMedCrossRef Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716PubMedCrossRef
19.
20.
go back to reference R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing
21.
go back to reference RStudio Team (2022) RStudio: integrated development environment for R. RStudio, PBC RStudio Team (2022) RStudio: integrated development environment for R. RStudio, PBC
23.
go back to reference Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48CrossRef Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48CrossRef
24.
go back to reference Harrer M, Cuijpers P, Furukawa T, Ebert DD (2019) Dmetar: companion R package for the guide 'Doing Meta-Analysis in R' Harrer M, Cuijpers P, Furukawa T, Ebert DD (2019) Dmetar: companion R package for the guide 'Doing Meta-Analysis in R'
25.
go back to reference McGuinness LA (2019) robvis: An R package and web application for visualising risk-of-bias assessments McGuinness LA (2019) robvis: An R package and web application for visualising risk-of-bias assessments
26.
go back to reference Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135PubMedPubMedCentralCrossRef Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135PubMedPubMedCentralCrossRef
27.
go back to reference Paule RC, Mandel J (1982) Consensus values and weighting factors. J Res Natl Bur Stand (1977) 87(5):377–385PubMedCrossRef Paule RC, Mandel J (1982) Consensus values and weighting factors. J Res Natl Bur Stand (1977) 87(5):377–385PubMedCrossRef
28.
go back to reference Sidik K, Jonkman JN (2002) A simple confidence interval for meta-analysis. Stat Med 21(21):3153–3159PubMedCrossRef Sidik K, Jonkman JN (2002) A simple confidence interval for meta-analysis. Stat Med 21(21):3153–3159PubMedCrossRef
29.
go back to reference Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693–2710PubMedCrossRef Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693–2710PubMedCrossRef
30.
go back to reference Hedges L (1981) Distribution theory for glass’s estimator of effect size and related estimators. J Educ Stat 6(2):107–128CrossRef Hedges L (1981) Distribution theory for glass’s estimator of effect size and related estimators. J Educ Stat 6(2):107–128CrossRef
31.
go back to reference Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef
32.
go back to reference Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008) Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61(10):991–996PubMedCrossRef Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008) Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61(10):991–996PubMedCrossRef
33.
go back to reference Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef
34.
35.
go back to reference Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002PubMedCrossRef Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002PubMedCrossRef
37.
go back to reference Tytgat G, Huibregtse K, Dagevos J, van den Ende A (1977) Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis. Am J Digestive Dis 22(8):669–676CrossRef Tytgat G, Huibregtse K, Dagevos J, van den Ende A (1977) Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis. Am J Digestive Dis 22(8):669–676CrossRef
38.
go back to reference Aly A, Barany F, Kollberg B, Monsen U, Wisen O, Johansson C (1980) Effect of an H2-receptor blocking agent on diarrhoeas after extensive small bowel resection in Crohn’s disease. Acta Med Scand 207(1–2):119–122PubMedCrossRef Aly A, Barany F, Kollberg B, Monsen U, Wisen O, Johansson C (1980) Effect of an H2-receptor blocking agent on diarrhoeas after extensive small bowel resection in Crohn’s disease. Acta Med Scand 207(1–2):119–122PubMedCrossRef
39.
go back to reference King R, Norton T, Hill G (1982) A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg 52(2):121–124PubMedCrossRef King R, Norton T, Hill G (1982) A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg 52(2):121–124PubMedCrossRef
40.
go back to reference Rodrigues CA, Lennard-Jones JE, Thompson DG, Farthing MJ (1989) The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther 3(2):159–169PubMedCrossRef Rodrigues CA, Lennard-Jones JE, Thompson DG, Farthing MJ (1989) The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther 3(2):159–169PubMedCrossRef
41.
go back to reference Beaugerie L, Cosnes J, Verwaerde F et al (1991) Isotonic high-sodium oral rehydration solution for increasing sodium absorption in patients with short-bowel syndrome. Am J Clin Nutr 53(3):769–772PubMedCrossRef Beaugerie L, Cosnes J, Verwaerde F et al (1991) Isotonic high-sodium oral rehydration solution for increasing sodium absorption in patients with short-bowel syndrome. Am J Clin Nutr 53(3):769–772PubMedCrossRef
42.
go back to reference Kusuhara K, Kusunoki M, Okamoto T, Sakanoue Y, Utsunomiya J (1992) Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201–995. Int J Colorectal Dis 7(4):202–205PubMedCrossRef Kusuhara K, Kusunoki M, Okamoto T, Sakanoue Y, Utsunomiya J (1992) Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201–995. Int J Colorectal Dis 7(4):202–205PubMedCrossRef
43.
go back to reference Jeppesen P, Staun M, Tjellesen L, Mortensen P (1998) Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 43(6):763–769PubMedPubMedCentralCrossRef Jeppesen P, Staun M, Tjellesen L, Mortensen P (1998) Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 43(6):763–769PubMedPubMedCentralCrossRef
44.
go back to reference Heydorn S, Jeppesen PB, Mortensen PB (1999) Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol 34(8):818–823PubMedCrossRef Heydorn S, Jeppesen PB, Mortensen PB (1999) Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol 34(8):818–823PubMedCrossRef
45.
go back to reference Ecker K-W, Stallmach A, Seitz G, Gierend M, Greinwald R, Achenbach U (2003) Oral budesonide significantly improves water absorption in patients with ileostomy for crohn disease. Scand J Gastroenterol 38(3):288–293PubMedCrossRef Ecker K-W, Stallmach A, Seitz G, Gierend M, Greinwald R, Achenbach U (2003) Oral budesonide significantly improves water absorption in patients with ileostomy for crohn disease. Scand J Gastroenterol 38(3):288–293PubMedCrossRef
46.
go back to reference Clarebrough E, Guest G, Stupart D (2015) Eating marshmallows reduces ileostomy output: a randomized crossover trial. Colorectal Dis 17(12):1100–1103PubMedCrossRef Clarebrough E, Guest G, Stupart D (2015) Eating marshmallows reduces ileostomy output: a randomized crossover trial. Colorectal Dis 17(12):1100–1103PubMedCrossRef
47.
go back to reference Kristensen K, Qvist N (2017) The acute effect of loperamide on ileostomy output: a randomized, double-blinded, placebo-controlled, crossover study. Basic Clin Pharmacol Toxicol 121(6):493–498PubMedCrossRef Kristensen K, Qvist N (2017) The acute effect of loperamide on ileostomy output: a randomized, double-blinded, placebo-controlled, crossover study. Basic Clin Pharmacol Toxicol 121(6):493–498PubMedCrossRef
48.
go back to reference Naimi RM, Hvistendahl M, Enevoldsen LH et al (2019) Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. Lancet Gastroenterol Hepatol 4(5):354–363PubMedCrossRef Naimi RM, Hvistendahl M, Enevoldsen LH et al (2019) Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. Lancet Gastroenterol Hepatol 4(5):354–363PubMedCrossRef
49.
go back to reference Mesli Y, Holterbach L, Delhorme J-B et al (2021) Is lanreotide really useful in high output stoma? Comparison between lanreotide to conventional antidiarrheal treatment alone. J Invest Surg 34(12):1312–1316PubMedCrossRef Mesli Y, Holterbach L, Delhorme J-B et al (2021) Is lanreotide really useful in high output stoma? Comparison between lanreotide to conventional antidiarrheal treatment alone. J Invest Surg 34(12):1312–1316PubMedCrossRef
50.
go back to reference Culkin A, Gabe SM, Nightingale JMD (2022) A new palatable oral rehydration solution: a randomised controlled cross-over study in patients with a high output stoma. J Hum Nutr Diet 35(1):94–101PubMedCrossRef Culkin A, Gabe SM, Nightingale JMD (2022) A new palatable oral rehydration solution: a randomised controlled cross-over study in patients with a high output stoma. J Hum Nutr Diet 35(1):94–101PubMedCrossRef
51.
go back to reference Lévy E, Palmer D, Frileux P, Parc R, Huguet C, Loygue J (1983) Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel. A clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 198(5):596–600PubMedPubMedCentralCrossRef Lévy E, Palmer D, Frileux P, Parc R, Huguet C, Loygue J (1983) Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel. A clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 198(5):596–600PubMedPubMedCentralCrossRef
52.
go back to reference Cooper JC, Williams NS, King RF, Barker MC (1986) Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg 73(2):128–131PubMedCrossRef Cooper JC, Williams NS, King RF, Barker MC (1986) Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg 73(2):128–131PubMedCrossRef
53.
go back to reference Jacobsen O, Ladefoged K, Stage JG, Jarnum S (1986) Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol 21(7):824–828PubMedCrossRef Jacobsen O, Ladefoged K, Stage JG, Jarnum S (1986) Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol 21(7):824–828PubMedCrossRef
54.
go back to reference Nightingale JM, Walker ER, Burnham WR, Farthing MJ, Lennard-Jones JE (1989) Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 3(4):367–373PubMedCrossRef Nightingale JM, Walker ER, Burnham WR, Farthing MJ, Lennard-Jones JE (1989) Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 3(4):367–373PubMedCrossRef
55.
go back to reference Nightingale J, Walker E, Farthing M, Lennard-Jones J (1991) Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 5(4):405–412PubMedCrossRef Nightingale J, Walker E, Farthing M, Lennard-Jones J (1991) Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 5(4):405–412PubMedCrossRef
56.
go back to reference O’Keefe SJ, Peterson ME, Fleming CR (1994) Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN J Parenter Enteral Nutr 18(1):26–34PubMedCrossRef O’Keefe SJ, Peterson ME, Fleming CR (1994) Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN J Parenter Enteral Nutr 18(1):26–34PubMedCrossRef
57.
go back to reference Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG (2001) An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 96(5):1494–1498PubMedCrossRef Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG (2001) An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 96(5):1494–1498PubMedCrossRef
58.
go back to reference Ecker KW, Stallmach A, Löffler J, Greinwald R, Achenbach U (2005) Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn’s disease and ileostomy. Dis Colon Rectum 48(2):237–242PubMedCrossRef Ecker KW, Stallmach A, Löffler J, Greinwald R, Achenbach U (2005) Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn’s disease and ileostomy. Dis Colon Rectum 48(2):237–242PubMedCrossRef
59.
go back to reference Jeppesen PB (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54(9):1224–1231PubMedPubMedCentralCrossRef Jeppesen PB (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54(9):1224–1231PubMedPubMedCentralCrossRef
60.
go back to reference Buchman A, Fryer J, Wallin A, Ahn C, Polensky S, Zaremba K (2006) Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. J Parenter Enter Nutr 30(6):487–491CrossRef Buchman A, Fryer J, Wallin A, Ahn C, Polensky S, Zaremba K (2006) Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. J Parenter Enter Nutr 30(6):487–491CrossRef
62.
go back to reference Hvistendahl M, Brandt CF, Tribler S et al (2016) Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome. J Parenter Enteral Nutr 42(1):112–121 Hvistendahl M, Brandt CF, Tribler S et al (2016) Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome. J Parenter Enteral Nutr 42(1):112–121
64.
go back to reference Chia CLK, Tai YS, Tan K-Y (2017) A preliminary study of the use of oral rehydration salts in decreasing ileostomy output. Tech Coloproctol 21(7):587–588PubMedCrossRef Chia CLK, Tai YS, Tan K-Y (2017) A preliminary study of the use of oral rehydration salts in decreasing ileostomy output. Tech Coloproctol 21(7):587–588PubMedCrossRef
65.
go back to reference Picot D, Layec S, Seynhaeve E, Dussaulx L, Trivin F, Carsin-Mahe M (2020) Chyme reinfusion in intestinal failure related to temporary double enterostomies and enteroatmospheric fistulas. Nutrients 12(5):1376PubMedPubMedCentralCrossRef Picot D, Layec S, Seynhaeve E, Dussaulx L, Trivin F, Carsin-Mahe M (2020) Chyme reinfusion in intestinal failure related to temporary double enterostomies and enteroatmospheric fistulas. Nutrients 12(5):1376PubMedPubMedCentralCrossRef
66.
go back to reference Sobocki J, Zaczek Z, Jurczak P et al (2021) Restricted vs. unrestricted oral intake in high output end-jejunostomy patients referred to reconstructive surgery. Br J Nutr 125(10):1125–1131PubMedCrossRef Sobocki J, Zaczek Z, Jurczak P et al (2021) Restricted vs. unrestricted oral intake in high output end-jejunostomy patients referred to reconstructive surgery. Br J Nutr 125(10):1125–1131PubMedCrossRef
67.
go back to reference Zaczek Z, Dabrowska K, Omidi M, Panczyk M, Sobocki J (2022) Effect of thickening powder on gastrointestinal losses in patients with high-output end jejunostomy syndrome—preliminary results. In Vivo 36(2):884–889PubMedPubMedCentralCrossRef Zaczek Z, Dabrowska K, Omidi M, Panczyk M, Sobocki J (2022) Effect of thickening powder on gastrointestinal losses in patients with high-output end jejunostomy syndrome—preliminary results. In Vivo 36(2):884–889PubMedPubMedCentralCrossRef
68.
go back to reference Nightingale JM, Lennard-Jones JE, Walker ER, Farthing MJ (1990) Jejunal efflux in short bowel syndrome. Lancet 336(8718):765–768PubMedCrossRef Nightingale JM, Lennard-Jones JE, Walker ER, Farthing MJ (1990) Jejunal efflux in short bowel syndrome. Lancet 336(8718):765–768PubMedCrossRef
69.
go back to reference Hara Y, Miura T, Sakamoto Y, Morohashi H, Nagase H, Hakamada K (2020) Organ/space infection is a common cause of high output stoma and outlet obstruction in diverting ileostomy. BMC Surg 20(1):83PubMedPubMedCentralCrossRef Hara Y, Miura T, Sakamoto Y, Morohashi H, Nagase H, Hakamada K (2020) Organ/space infection is a common cause of high output stoma and outlet obstruction in diverting ileostomy. BMC Surg 20(1):83PubMedPubMedCentralCrossRef
70.
go back to reference Teitelbaum EN, Vaziri K, Zettervall S, Amdur RL, Orkin BA (2013) Intraoperative small bowel length measurements and analysis of demographic predictors of increased length. Clin Anat 26(7):827–832PubMedCrossRef Teitelbaum EN, Vaziri K, Zettervall S, Amdur RL, Orkin BA (2013) Intraoperative small bowel length measurements and analysis of demographic predictors of increased length. Clin Anat 26(7):827–832PubMedCrossRef
71.
go back to reference Tacchino RM (2015) Bowel length: measurement, predictors, and impact on bariatric and metabolic surgery. Surg Obes Relat Dis 11(2):328–334PubMedCrossRef Tacchino RM (2015) Bowel length: measurement, predictors, and impact on bariatric and metabolic surgery. Surg Obes Relat Dis 11(2):328–334PubMedCrossRef
Metadata
Title
Clinical management of high-output stoma: a systematic literature review and meta-analysis
Authors
H. Lederhuber
L. H. Massey
V. E. Kantola
M. R. S. Siddiqui
A. E. Sayers
F. D. McDermott
I. R. Daniels
N. J. Smart
Publication date
18-06-2023
Publisher
Springer International Publishing
Published in
Techniques in Coloproctology / Issue 12/2023
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-023-02830-1

Other articles of this Issue 12/2023

Techniques in Coloproctology 12/2023 Go to the issue
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now